Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: Results from the pulmonary hypertension registry of the United Kingdom and Ireland

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 8, 2012, Pages 790-796

  Ling, Yi ^a   Johnson, Martin K ^a   Kiely, David G ^b   Condliffe, Robin ^b   Elliot, Charlie A ^b   Gibbs, J Simon R ^c   Howard, Luke S ^c   Pepke Zaba, Joanna ^d   Sheares, Karen K K ^d   Corris, Paul A ^e   Fisher, Andrew J ^e   Lordan, James L ^e   Gaine, Sean ^f   Coghlan, J Gerry ^g   Wort, S John ^h   Gatzoulis, Michael A ^h   Peacock, Andrew J ^a  

^a GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d PAPWORTH HOSPITAL   (United Kingdom)

^e FREEMAN HOSPITAL   (United Kingdom)

^f MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^g ROYAL FREE HOSPITAL   (United Kingdom)

^h ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Aging; Epidemiology; Pulmonary hypertension; Survival

Indexed keywords

ANOREXIGENIC AGENT; CARBON MONOXIDE;

ADULT; ARTICLE; BODY MASS; COMORBIDITY; COUGHING; DEMOGRAPHY; DIABETES MELLITUS; DISEASE DURATION; DISEASE REGISTRY; DIZZINESS; DYSPNEA; ETHNICITY; EXERCISE; FAINTNESS; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HEMOPTYSIS; HEREDITY; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IDIOPATHIC DISEASE; INCIDENCE; IRELAND; ISCHEMIC HEART DISEASE; LUNG FUNCTION; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL EDEMA; PRESYNCOPE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; SMOKING; SURVIVAL; THORAX PAIN; UNITED KINGDOM; WEIGHT REDUCTION;

ADULT; AGE DISTRIBUTION; AGED; COMORBIDITY; FEMALE; GREAT BRITAIN; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; IRELAND; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 84867599718     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201203-0383OC     Document Type: Article

References (30)

1. Tueller C, Stricker H, Soccal P, Tamm M, Aubert JD, Maggiorini M, Zwahlen M, Nicod L. Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss Med Wkly 2008;138:379-384. (Pubitemid 351969707)
2. Stricker H, Domenighetti G, Popov W, Speich R, Nicod L, Aubert JD, Soler M. Severe pulmonary hypertension: data from the Swiss Registry. Swiss Med Wkly 2001;131:346-350. (Pubitemid 32666249)
3. Jing ZC, Xu XQ, Han ZY, Wu Y, Deng KW, Wang H, Wang ZW, Cheng XS, Xu B, Hu SS, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 2007;132:373-379. (Pubitemid 47282365)
4. Appelbaum L, Yigla M, Bendayan D, Reichart N, Fink G, Priel S, Schwartz Y, Richman P, Picard E,Goldman S, et al. Primary pulmonary hypertension in Israel: a national survey. Chest 2001;119:1801-1806. (Pubitemid 32744938)
5. Rich S, Dantzker D, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-223. (Pubitemid 17137857)
6. D'Alonzo GE, Barst R, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al. Survival in patients with primary pulmonary-hypertension: results from a national prospective registry. Ann Intern Med 1991;115:343-349.
7. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023-1030.
8. Badesch DB, Raskob G, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, et al. Pulmonary arterial hypertension baseline characteristics from the REVEAL registry. Chest 2010;137:376-387.
9. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007;30:1103-1110. (Pubitemid 351194756)
10. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010;36:549-555.
11. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010;122:156-163.
12. Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010;35:1079-1087.
13. National Pulmonary Hypertension Centres of the UK and Ireland. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Heart 2008;94:i1-i41.
14. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, et al. Predicting survival in pulmonary arterial hypertension insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010;122:164-172.
15. Benza RL, Gomberg-Maitland M, Miller DP, Frost A, Frantz RP, Foreman AJ, Badesch DB, McGoon MD. The REVEAL risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest 2012;141:354-362.
16. Ling Y, Johnson M, Kiely D, Condliffe R, Elliot C, Gibbs S, Howard L, Pepke-Zaba J, Sheares K, Corris P, et al. Demographic trends and changes in long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009: results from the Pulmonary Hypertension Registry of the UK and Ireland [abstract]. Presented at the European Respiratory Society Annual Congress, September 24-28, 2011, Amsterdam, The Netherlands.
17. Ling Y, Johnson M, Kiely D, Condliffe R, Elliot C, Gibbs S, Howard L, Pepke-Zaba J, Sheares K, Corris P, et al. Influence of age on clinical phenotypes of incident idiopathic pulmonary arterial hypertension: results from the Pulmonary Hypertension Registry of the UK and Ireland [abstract]. Thorax 2011;66:A34-A5.
18. Ling Y, Johnson M, Kiely D, Condliffe R, Elliot C, Gibbs S, Howard L, Pepke-Zaba J, Sheares K, Corris P, et al. Prediction of survival in pulmonary arterial hypertension using survival equations: results from the Pulmonary Hypertension Registry of the UK and Ireland [abstract]. Thorax 2011;66:A35-A36.
19. Souza R, Humbert M, Sztrymf B, Jais X, Yaici A, Le Pavec J, Parent F, Herve P, Soubrier F, Sitbon O, et al. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J 2008;31:343-348.
20. Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007;30:104-109. (Pubitemid 47074013)
21. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21:128-138.
22. Brier G. Verification of forecasts expressed in terms of probability. Mon Weather Rev 1950;78:1-3.
23. Gerds TA, Cai T, Schumacher M. The performance of risk prediction models. Biom J 2008;50:457-479.
24. Shapiro BP, McGoon MD, Redfield MM. Unexplained pulmonary hypertension in elderly patients. Chest 2007;131:94-100. (Pubitemid 46122979)
25. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009;136:37-43.
26. National Pulmonary Hypertension Centres of the UK and Ireland. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Thorax 2008;63:ii1-ii41.
27. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al.; Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-1263.
28. Moledina S, Hislop AA, Foster H, Schulze-Neick I, Haworth SG. Childhood idiopathic pulmonary arterial hypertension: a national cohort study. Heart 2010;96:1401-1406.
29. Crapo RO, Hankinson JL, Irvin C, MacIntyre NR, Zoter KZ, Rise RA. Single-breath carbon monoxide diffusion capacity (transfer factor). Recommendations for a standard technique: 1995 update. Am J Respir Crit Care Med 1995;152:2185-2198.
30. Sherrill DL, Enright PL, Kaltenborn Walter T, Lebowitz Michael D. Predictors of longitudinal change in diffusion capacity over 8 years. Am J Respir Crit Care Med 1999;160:1883-1887. (Pubitemid 30004691)